CONDENSED STATEMENT OF CASH FLOWS - USD ($)
|
2 Months Ended |
9 Months Ended |
Dec. 31, 2019 |
Sep. 30, 2020 |
| Cash Flows from Operating Activities: |
|
|
| Net loss |
$ (17,631)
|
$ (2,349,569)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Interest earned on cash and marketable securities held in Trust Account |
|
(96,607)
|
| Changes in operating assets and liabilities: |
|
|
| Prepaid expenses |
|
(465,382)
|
| Accrued expenses |
|
1,807,280
|
| Net cash used in operating activities |
(17,631)
|
(1,104,278)
|
| Cash Flows from Investing Activities: |
|
|
| Investment of cash in Trust Account |
|
(828,000,000)
|
| Net cash used in investing activities |
|
(828,000,000)
|
| Cash Flows from Financing Activities: |
|
|
| Proceeds from issuance of Class B ordinary shares to Sponsor |
|
25,000
|
| Proceeds from sale of Units, net of underwriting discounts paid |
|
813,600,000
|
| Advances from related party |
17,631
|
|
| Proceeds from sale of Private Placement Warrants |
|
16,400,000
|
| Repayment of advances from related parties |
|
(17,631)
|
| Proceeds from promissory note - related party |
|
300,000
|
| Repayment of promissory note - related party |
|
(300,000)
|
| Payment of offering costs |
|
(776,346)
|
| Net cash provided by financing activities |
17,631
|
829,231,023
|
| Net Change in Cash |
|
126,745
|
| Cash - Beginning |
|
0
|
| Cash - End of period |
0
|
126,745
|
| Non-cash investing and financing activities: |
|
|
| Deferred offering costs included in accrued offering costs |
$ 100,346
|
|
| Initial classification of ordinary shares subject to possible redemption |
|
795,251,020
|
| Change in value of ordinary shares subject to possible redemption |
|
(2,349,569)
|
| Deferred underwriting fee |
|
$ 28,980,000
|